Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expanded use of surfactant replacement therapy.

A Greenough1

  • 1Department of Child Health, King's College Hospital, London, UK. anne.greenough@kcl.ac.uk

European Journal of Pediatrics
|October 3, 2000
PubMed
Summary

Exogenous surfactant improves oxygenation and reduces the need for mechanical ventilation and intensive care in infants with respiratory diseases. Further trials are needed to confirm benefits and cost-effectiveness in non-respiratory distress syndrome conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-invasive carbon dioxide monitoring in the UK: a survey of practice within neonatal intensive care.

Anaesthesia·2021
Same author

Review finds insufficient evidence to support the routine use of heated, humidified high-flow nasal cannula use in neonates.

Acta paediatrica (Oslo, Norway : 1992)·2014
Same author

Airways obstruction and pulmonary capillary blood volume in children with sickle cell disease.

Pediatric pulmonology·2013
Same author

Predictors of neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetoscopic tracheal occlusion.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2013
Same author

Antenatal and postnatal management of congenital cystic adenomatoid malformation.

Paediatric respiratory reviews·2012
Same author

Congenital diaphragmatic hernia.

The European respiratory journal·2011

Area of Science:

  • Neonatal respiratory medicine
  • Pulmonology
  • Biochemistry

Background:

  • Infant respiratory diseases often involve surfactant dysfunction or deficiency.
  • Surfactant activity can be inhibited by various factors including meconium, hemoglobin, and plasma proteins.
  • Viral infections and neutrophil metabolites can impair surfactant production by type 2 pneumocytes.

Purpose of the Study:

  • To evaluate the efficacy of exogenous surfactant in various infant respiratory disorders beyond respiratory distress syndrome.
  • To assess the impact of surfactant administration on oxygenation, mechanical ventilation, and intensive care unit (ICU) stay.

Main Methods:

  • Review of studies, including animal models, anecdotal series, and randomized trials, on exogenous surfactant use in infant respiratory conditions.
  • Analysis of outcomes such as oxygenation, need for extracorporeal membrane oxygenation (ECMO), airleaks, ventilation duration, and ICU stay.

Main Results:

  • Exogenous surfactant generally improves oxygenation in infants with respiratory disorders.
  • Randomized trials show longer-term benefits, including reduced ECMO duration and need.
  • Surfactant treatment decreased airleaks, ventilation duration, and ICU stay in meconium aspiration syndrome and bronchiolitis.

Conclusions:

  • Surfactant administration shows promising results in improving outcomes for infants with specific respiratory conditions.
  • Further randomized trials are essential to determine optimal surfactant types, dosages, and administration methods.
  • Cost-benefit analysis is needed to fully establish the value of surfactant treatment in non-respiratory distress syndrome respiratory diseases.

Related Experiment Videos